PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody[MIAP410]

PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody[MIAP410]

The PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] is a highly specific and reliable tool for the detection and analysis of CD47 expression in human, mouse, and rat samples. This antibody is conjugated with PE/Cyanine5.5, a bright and photostable fluorochrome, ensuring accurate and consistent results.

CD47, also known as integrin-associated protein (IAP), is a transmembrane protein that plays a crucial role in various physiological processes, including cell adhesion, migration, and immune response regulation. Aberrant CD47 expression has been implicated in numerous diseases, making it an important target for research and therapeutic development.

The PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] exhibits exceptional specificity, binding only to CD47 and not cross-reacting with other antigens. This specificity is essential for obtaining reliable and reproducible data in various experimental applications, such as flow cytometry, immunofluorescence, and immunohistochemistry.

With its PE/Cyanine5.5 conjugation, this antibody offers several advantages. PE/Cyanine5.5 is a bright fluorochrome with high quantum yield, enabling sensitive detection of CD47 expression even at low levels. Additionally, it possesses excellent photostability, ensuring consistent signal intensity throughout prolonged experiments.

The PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] is supplied as a ready-to-use solution, eliminating the need for time-consuming conjugation procedures. It is provided in a convenient format, allowing for easy integration into existing laboratory protocols.

In summary, the PE/Cyanine5.5 Anti-Human/Mouse/Rat CD47 Antibody [MIAP410] is a highly specific and reliable tool for the detection and analysis of CD47 expression. Its exceptional specificity, bright fluorochrome conjugation, and ready-to-use format make it an ideal choice for researchers in the fields of immunology, oncology, and drug discovery.